GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Virtus Convertible & Income Fund II (NYSE:NCZ) » Definitions » Research & Development

Virtus Convertible &ome Fund II (Virtus Convertible &ome Fund II) Research & Development : $0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Virtus Convertible &ome Fund II Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Virtus Convertible &ome Fund II's Research & Development for the six months ended in Jan. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00 Mil.


Virtus Convertible &ome Fund II Research & Development Historical Data

The historical data trend for Virtus Convertible &ome Fund II's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virtus Convertible &ome Fund II Research & Development Chart

Virtus Convertible &ome Fund II Annual Data
Trend Feb18 Feb19 Feb20 Feb21 Jan23 Jan24
Research & Development
Get a 7-Day Free Trial - - - - -

Virtus Convertible &ome Fund II Semi-Annual Data
Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Jul22 Jan23 Jul23 Jan24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Virtus Convertible &ome Fund II Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Virtus Convertible &ome Fund II  (NYSE:NCZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Virtus Convertible &ome Fund II Research & Development Related Terms

Thank you for viewing the detailed overview of Virtus Convertible &ome Fund II's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Virtus Convertible &ome Fund II (Virtus Convertible &ome Fund II) Business Description

Traded in Other Exchanges
N/A
Address
101 Munson Street, Greenfield, MA, USA, 01301
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.
Executives
Metlife Investment Management, Llc 10 percent owner ONE METLIFE WAY, WHIPPANY NJ 07981
Mcdaniel Connie D director C/O VIRTUS INVESTMENT PARTNERS, INC., ONE FINANCIAL PLAZA, 26TH FL., HARTFORD CT 06103
Geraldine M Mcnamara director 150 EAST 44TH ST, APT 35G, NEW YORK NY 10017
R Keith Walton director 100 PEARL STREET, HARTFORD CT 06103
Christine Hurtsellers other: CEO - Subadviser to the issuer 230 PARK AVENUE, NEW YORK NY 10169
Vincent J Costa other: CIO-Subadviser to the issuer 800 SCUDDERS MILL ROAD, PLAINSBORO NJ 08536
Paul Zemsky other: CIO-Subadviser to the issuer 230 PARK AVENUE, NEW YORK NY 10169
Voya Investment Management Co other: Subadviser to the issuer 10 STATE HOUSE SQUARE, SH12, HARTFORD CT 06103-3602
Brian T Zino director 100 PARK AVENUE, NEW YORK NY 10017
Deborah A Decotis director 1633 BROADWAY, NEW YORK NY 10019
Michael Yee officer: Portfolio Manager C/O ALLIANZ EQUITY ADVISORS, 1345 AVE OF THE AMERICAS, NEW YORK NY 10105
David J. Oberto officer: Portfolio Manager 1633 BROADWAY, NEW YORK NY 10019
George R Aylward director, officer: President and CEO C/O VIRTUS INVESTMENT PARTNERS, INC., 100 PEARL STREET, HARTFORD CT 06103
James S Macleod director 250 E KILBOURN AVE, MILWAUKEE WI 53202
Richard W Smirl officer: EVP C/O VIRTUS INVESTMENT PARTNERS, INC., ONE FINANCIAL PLAZA, HARTFORD CT 06103

Virtus Convertible &ome Fund II (Virtus Convertible &ome Fund II) Headlines